Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

NCT00488319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizophrenic Disorders
Psychotic Disorders
Dementia Praecox

Interventions

DRUG: Paliperidone ER

Sponsor

Janssen Research & Development, LLC